HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells.

Lyu, Hui; Hou, Defu; Liu, Hao; Ruan, Sanbao; Tan, Congcong; Wu, Jiande; Hicks, Chindo; Liu, Bolin.

Afiliación

Lyu H; Departments of Interdisciplinary Oncology, Louisiana State University (LSU) Health Sciences Center, New Orleans, LA, USA. hlyu@lsuhsc.edu.
Hou D; Departments of Genetics, Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University (LSU) Health Sciences Center, New Orleans, LA, USA. hlyu@lsuhsc.edu.
Liu H; Departments of Interdisciplinary Oncology, Louisiana State University (LSU) Health Sciences Center, New Orleans, LA, USA.
Ruan S; Department of Biochemistry and Molecular Biology, School of Medicine, Hunan Normal University, Changsha, Hunan, China.
Tan C; Departments of Interdisciplinary Oncology, Louisiana State University (LSU) Health Sciences Center, New Orleans, LA, USA.
Wu J; Departments of Interdisciplinary Oncology, Louisiana State University (LSU) Health Sciences Center, New Orleans, LA, USA.
Hicks C; Departments of Interdisciplinary Oncology, Louisiana State University (LSU) Health Sciences Center, New Orleans, LA, USA.
Liu B; Departments of Genetics, Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University (LSU) Health Sciences Center, New Orleans, LA, USA.

NPJ Precis Oncol ; 7(1): 72, 2023 Aug 03.

Article en En | MEDLINE | ID: mdl-37537339

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2023 Tipo del documento: Article